Breaking News

Monday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ADMS

Adamas Pharmaceuticals

$21.89

-0.28 (-1.26%)

07:31
09/17/18
09/17
07:31
09/17/18
07:31
Recommendations
Adamas Pharmaceuticals analyst commentary at H.C. Wainwright »

Adamas COO departure…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADMS

Adamas Pharmaceuticals

$21.89

-0.28 (-1.26%)

06:23
09/17/18
09/17
06:23
09/17/18
06:23
Recommendations
Adamas Pharmaceuticals analyst commentary at Mizuho »

Adamas COO departure does…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a week ago
ADMS

Adamas Pharmaceuticals

$21.89

-0.28 (-1.26%)

16:22
09/14/18
09/14
16:22
09/14/18
16:22
Hot Stocks
Adamas Pharmaceuticals COO to leave company, citing personal reasons »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
ADMS

Adamas Pharmaceuticals

$24.28

-1.55 (-6.00%)

07:29
08/07/18
08/07
07:29
08/07/18
07:29
Recommendations
Adamas Pharmaceuticals analyst commentary at H.C. Wainwright »

Adamas patient deaths…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADMS

Adamas Pharmaceuticals

$24.31

-1.52 (-5.88%)

15:57
08/06/18
08/06
15:57
08/06/18
15:57
Periodicals
Adamas says data on FAERS consistent with prescribing info, Bloomberg reports »

In a statement to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADMS

Adamas Pharmaceuticals

$24.50

-1.33 (-5.15%)

15:38
08/06/18
08/06
15:38
08/06/18
15:38
Hot Stocks
Adamas weakness attributed to deaths shown in FAERS database »

Shares of Adamas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADMS

Adamas Pharmaceuticals

$24.92

0.74 (3.06%)

16:21
08/02/18
08/02
16:21
08/02/18
16:21
Earnings
Adamas Pharmaceuticals reports Q2 EPS ($1.26), consensus ($1.41) »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

ADMS

Adamas Pharmaceuticals

$24.21

0.45 (1.89%)

16:05
08/01/18
08/01
16:05
08/01/18
16:05
Syndicate
Adamas Pharmaceuticals fles to sell common stock, no amount given »

Raymond James &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

ADMS

Adamas Pharmaceuticals

$27.05

0.78 (2.97%)

07:08
07/16/18
07/16
07:08
07/16/18
07:08
Initiation
Adamas Pharmaceuticals initiated at H.C. Wainwright »

Adamas Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a quarter ago
ADMS

Adamas Pharmaceuticals

$25.52

(0.00%)

09:18
06/22/18
06/22
09:18
06/22/18
09:18
Hot Stocks
Adamas says new data shows GOCOVRI reduces transitions between dyskinesia, OFF »

Adamas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.